Concepedia

Hallucinogen Discrimination

Hallucinogen Discrimination is a behavioral pharmacology paradigm, within the broader class of drug discrimination procedures, that specifically enables an organism to distinguish the interoceptive stimulus properties of hallucinogenic drugs from those of non-hallucinogenic agents, thereby serving as a translational method to study the perceptual and neuropharmacological mechanisms underlying hallucinogenic effects.

30

Publications

1.3K

Citations

61

Authors

29

Institutions

Publications per year

2017–2026

1

Parents

Publications

30

Dihydrobenzofuran Analogues of Hallucinogens. 3. Models of 4-Substituted (2,5-Dimethoxyphenyl)alkylamine Derivatives with Rigidified Methoxy Groups

Aaron Monte, Danuta Marona‐Lewicka, Matthew Parker et al. · Journal of Medicinal Chemistry · 1996 · 106 citations · Full text

, , +15

Mescaline and lysergic acid diethylamide (LSD) as discriminative stimuli

Ira D. Hirschhorn, J.C. Winter · Psychopharmacology · 1971 · 105 citations

, , +10

Dihydrobenzofuran Analogues of Hallucinogens. 4. Mescaline Derivatives

Aaron Monte, Steve R. Waldman, Danuta Marona‐Lewicka et al. · Journal of Medicinal Chemistry · 1997 · 89 citations · Full text

, , +12

Analyzing mechanism(s) of hallucinogenic drug action with drug discrimination procedures

J. B. Appel, Francis J. White, Alice M. Holohean · Neuroscience & Biobehavioral Reviews · 1982 · 76 citations

, , +8

Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines

J.C. Winter · Psychopharmacology · 2008 · 70 citations · Full text

, , +11

1–5 of 30

Authors

61

  1. RY
    Richard Young

    Virginia Commonwealth University Medical Center, United States

    5 publications · 160 citations

    5

    h-index

  2. RA
    Richard A. Glennon

    Virginia Commonwealth University Medical Center, United States

    4 publications · 113 citations

    4

    h-index

  3. DE
    David E. Nichols

    Purdue University West Lafayette, United States

    4 publications · 273 citations

    4

    h-index

  4. DM
    Danuta Marona‐Lewicka

    Purdue University West Lafayette, United States

    3 publications · 239 citations

    3

    h-index

  5. JB
    J. B. Appel

    University of South Carolina, United States

    3 publications · 131 citations

    3

    h-index

1–5 of 61

Institutions

29

  1. University of South Carolina

    Columbia, United States

    5 h-index

    11 publications

    407 citations

  2. Behavioral Pharma (United States)

    La Jolla, United States

    4 h-index

    10 publications

    352 citations

  3. Purdue University West Lafayette

    West Lafayette, United States

    3 h-index

    16 publications

    1.4K citations

  4. Virginia Commonwealth University Medical Center

    Richmond, United States

    3 h-index

    8 publications

    237 citations

  5. Indiana University – Purdue University Indianapolis

    Indianapolis, United States

    2 h-index

    13 publications

    1.3K citations

  6. University at Buffalo, State University of New York

    Buffalo, United States

    2 h-index

    3 publications

    280 citations

  7. Eli Lilly (United States)

    Indianapolis, United States

    2 h-index

    13 publications

    1.3K citations

  8. University of North Texas

    Denton, United States

    2 h-index

    4 publications

    110 citations

1–8 of 29

Venues

  1. 7

    h-index

  2. PubMed

    Repository · 5 publications · 189 citations

    5

    h-index

  3. Psychopharmacology

    5 publications · 280 citations

    5

    h-index

  4. Journal of Medicinal Chemistry

    3 publications · 229 citations

    3

    h-index

  5. Pharmacology Biochemistry and Behavior

    3 publications · 76 citations

    3

    h-index

1–5